Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thursday, March 29, 2012 - 5:19pm
tags:
Biomarin, Amicus Therapeutics, Sanofi, Vertex
Will Obesity Drugs Do Better in Europe?
Motley Fool
Thursday, March 29, 2012 - 12:16pm
tags:
obsesity, Arena, Vivus, Orexigen, lorcaserin, Contrave, Qnexa
Discovery Laboratories posts smaller 4th-qtr loss on lower expenses, stock-related gain
Yahoo/AP
Thursday, March 29, 2012 - 12:13pm
tags:
earnings, Discovery Labs
Judge denies AZ's bid to stop Seroquel copies, but chides FDA
Fierce Pharma
Thursday, March 29, 2012 - 12:09pm
tags:
FDA, Seroquel, generics, AstraZeneca, Teva Pharmaceuticals, Mylan
FDA extends review period for Forest Lab lung drug
Reuters
Thursday, March 29, 2012 - 12:07pm
tags:
COPD, Forest Labs, FDA, Almirall
Breathe Easy: Relovair Program Complete, Data Solid
Motley Fool
Thursday, March 29, 2012 - 12:02pm
tags:
Relovair, GSK, Theravance, Advair
GlaxoSmithKline: A Solid Dividend Pick For 2012
Seeking Alpha
Thursday, March 29, 2012 - 11:59am
tags:
GSK, Abbott Laboratories, JNJ, dividends
Abbott: Expect Strong Upside Movement, Both Pre And Post Research Division Spin-Off
Seeking Alpha
Thursday, March 29, 2012 - 11:58am
tags:
Abbott Laboratories, JNJ, Merck, Pfizer, Sanofi, Watson Pharmaceuticals
Roche may raise bid again if Illumina engaged: source
Reuters
Thursday, March 29, 2012 - 11:57am
tags:
Illumina, Roche, M&A
FDA rejects Chelsea's Northera, demands additional study data
Fierce Biotech
Thursday, March 29, 2012 - 10:26am
tags:
FDA, Northera, Chelsea Therapeutics, neurogenic orthostatic hypotension
Watson Said to Be in Talks to Buy Swiss Drugmaker Actavis
Bloomberg
Thursday, March 29, 2012 - 10:20am
tags:
Watson, Actavis, M&A
Will Amylin Be Acquired? What The Wags Say…
Pharmalot
Thursday, March 29, 2012 - 10:18am
tags:
M&A, Bristol-Myers Squibb, Eli Lilly, AstraZeneca
Astellas extends deal to sell Pfizer's Lipitor in Japan
Reuters
Thursday, March 29, 2012 - 10:02am
tags:
Pfizer, Lipitor, statins, Japan, Astellas
Eli Lilly says psoriasis drug meets goal in study
Yahoo/AP
Thursday, March 29, 2012 - 10:01am
tags:
psoriasis, Eli Lilly, ixekizumab
Horizon Pharma sues Par Pharma over arthritis drug patent
Reuters
Thursday, March 29, 2012 - 9:57am
tags:
Par Pharmaceutical, Horizon Pharma, patents, Duexis, arthritis
FDA adds warnings to Forest Labs' Celexa label
Reuters
Wednesday, March 28, 2012 - 4:19pm
tags:
warnings, FDA, Forest Labs, Celexa, antidepressants
Mixed Data on Merck's Vorapaxar
Yahoo/Zacks.com
Wednesday, March 28, 2012 - 4:14pm
tags:
Merck, Vorapaxar, TRA-2P
Here's Where Abbott Laboratories Is Finding Its Growth
Motley Fool
Wednesday, March 28, 2012 - 4:05pm
tags:
Abbott Laboratories
Bristol-Myers in partnership for Alzheimer's test
Yahoo/AP
Wednesday, March 28, 2012 - 4:04pm
tags:
Alzheimer's disease, Bristol-Myers Squibb, Meso Scale Discovery
FDA OKs New Anemia Med That Challenges Amgen
Pharmalot
Wednesday, March 28, 2012 - 11:27am
tags:
FDA, Amgen, anemia, Epogen, Omontys, Affymax, Aranesp

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.